Tag: embolic liquid
iVascular announces Phase II results for Amber liquid embolic
New Phase II data from the OPAL study, evaluating iVascular's novel liquid embolic Amber ahead of its market launch, were presented at the Cardiovascular...
Fluidx Medical announces first patient treated in prospective trial
Fluidx Medical has announced that the first patient has been treated in the GPX investigational device exception (IDE) prospective multinational clinical trial.
The GPX...
